EFFECT OF PROSTACYCLIN (PGI2) ON PLATELETS AND FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH ARTERIOSCLEROSIS OBLITERANS

被引：15
|
作者：
DEMBINSKAKIEC, A
KOSTKATRABKA, E
ZMUDA, A
BYRSKADANEK, A
BIERON, K
GRODZINSKA, L
KEDZIOR, A
ZELAZNY, T
机构：
来源：
PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1982年 / 14卷 / 06期
关键词：
D O I：
10.1016/S0031-6989(82)80039-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：485 / 498
页数：14
相关论文
共 50 条
  • [31] HYPOTENSIVE EFFECT IN THE RAT AFTER ORAL PROSTACYCLIN (PGI2)
    CESERANI, R
    GROSSONI, M
    UKMAR, G
    MONGELLI, N
    PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1985, 18 (01): : 53 - 57
  • [32] MEASUREMENT OF THE DISAGGREGATING EFFECT OF PROSTACYCLIN (PGI2) IN ANESTHETIZED DOGS
    HERMAN, F
    HADHAZY, P
    MAGYAR, K
    BIOMEDICA BIOCHIMICA ACTA, 1984, 43 (8-9) : S377 - S380
  • [33] THE EFFECT OF VENTILATORY PATTERNS ON PROSTACYCLIN (PGI2) SYNTHESIS IN THE LUNG
    DUTOIT, HJ
    ERASMUS, FR
    MACFARLANE, CM
    TALJAARD, JJF
    SHEPHARD, EG
    KING, JB
    DEKLERK, AJ
    SOUTH AFRICAN MEDICAL JOURNAL, 1984, 65 (04): : 135 - 136
  • [34] BLEEDING IN UREMIC PATIENTS - POSSIBLE ROLE FOR PROSTACYCLIN (PGI2)
    REMUZZI, G
    CAVENAGHI, AE
    MECCA, G
    DONATI, MB
    GAETANO, GD
    BLOOD, 1977, 50 (05) : 280 - 280
  • [35] SIMPLE AND SENSITIVE ASSAY FOR PROSTACYCLIN (PGI2) - STUDY OF THE STRUCTURE-ACTIVITY RELATIONSHIP OF VARIOUS PGI2 ANALOGS
    KRISHNA, G
    KIM, N
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 1104 - 1104
  • [36] PROSTACYCLIN (PGI2) AND BLEEDING-TIME IN UREMIC PATIENTS
    REMUZZI, G
    CAVENAGHI, AE
    MECCA, G
    DONATI, MB
    GAETANO, GD
    THROMBOSIS RESEARCH, 1977, 11 (06) : 919 - 920
  • [37] ACTION OF MAGNESIUM-SULFATE ON PLATELETS AND BLOOD-VESSEL PROSTACYCLIN (PGI2)
    BRIEL, RC
    LIPPERT, TH
    ZAHRADNIK, H
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1984, 3 (2-3): : 135 - 135
  • [38] PROSTACYCLIN (PGI2) INHIBITS THE DEVELOPMENT IN PLATELETS OF ADP AND ARACHIDONATE-MEDIATED SHAPE CHANGE AND PROCOAGULANT ACTIVITY
    EHRMAN, M
    JAFFE, EA
    WEKSLER, BB
    CLINICAL RESEARCH, 1979, 27 (02): : A293 - A293
  • [39] THE ROLE OF PROSTACYCLIN (PGI2) IN METABOLIC HYPEREMIA
    FONDACARO, JD
    JACOBSON, ED
    PROSTAGLANDINS, 1981, 21 : 25 - 32
  • [40] ANTISECRETORY AND CYTOPROTECTIVE EFFECTS OF PROSTACYCLIN (PGI2)
    ROBERT, A
    HANCHAR, AJ
    LANCASTER, C
    NEZAMIS, JE
    FEDERATION PROCEEDINGS, 1978, 37 (03) : 460 - 460
12345